Shows & Panels
- The 2014 Big Picture on Cyber Security
- AFCEA Answers
- Ask the CIO
- Building the Hybrid Cloud
- Connected Government: How to Build and Procure Network Services for the Future
- Continuing Diagnostics and Mitigation: Discussion of Progress and Next Steps
- Federal Executive Forum
- Federal Tech Talk
- The Intersection: Where Technology Meets Transformation
- Maximizing ROI Through Data Center Consolidation
- Moving to the Cloud. What's the best approach for me
- Navigating Tough Choices in Government Cloud Computing
- The New Generation of Database
- Satellite Communications: Acquiring SATCOM in Tight Times
- Targeting Advanced Threats: Proven Methods from Detection through Remediation
- Transformative Technology: Desktop Virtualization in Government
- The Truth About IT Opex and Software Defined Networking
- Value of Health IT
Shows & Panels
Healthcare IT and clinical testing
Tuesday - 3/12/2013, 7:18pm EDT
Many will argue that improving healthcare IT will reduce the cost that Americans pay.
Both of these aspects of the federal government come together when you consider clinical testing.
Clinical testing is, of course, the way new drugs are scientifically tested over a long period of time to assure users that the benefits outweigh the risks.
Today, these tests must comply with regulation from the Food and Drug Administration (FDA).
Today's guest is Tony Varano, the founder and CEO of a company called DSG.
His company has spent the past twenty years working with companies to help them comply with the rigorous processes that the FDA has for vetting medicine.
They have been at 25,000 sites, participated in 1,000 clinical trials, worked with 400 companies in over 90 countries.
During the interview, Varano discusses best practices for collecting data and also gives some suggestions for making improvements in the process.